CKDXF
Price:
$0.01
Market Cap:
$12.39M
Ceryvyn Therapeutics Ltd is a clinical-stage biopharmaceutical company developing therapies for the rare lung disease lymphangioleiomyomatosis (LAM). Its lead program, CYV-101, is a fusion protein designed to neutralize VEGF-C and VEGF-D, key signaling proteins involved in the disease. The company was formerly known as Opthea Limited.
Industry
Biotechnology
IPO Date
2011-10-25
Stock Exchange
OTC
Ticker
CKDXF
According to Ceryvyn Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is -312.02%. This represents a change of -201.91% compared to the average of 306.17% of the last 4 quarters.
The mean historical ROE of Ceryvyn Therapeutics Limited over the last ten years is 237.28%. The current -312.02% ROE has changed -231.50% with respect to the historical average. Over the past ten years (40 quarters), CKDXF's ROE was at its highest in in the June 2023 quarter at 1.10%. The ROE was at its lowest in in the June 2022 quarter at -166.36%.
Average
237.28%
Median
-29.30%
Minimum
-183.45%
Maximum
2.41%
Discovering the peaks and valleys of Ceryvyn Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 443.81%
Maximum Annual ROE = 2.41%
Minimum Annual Increase = -1413.52%
Minimum Annual ROE = -183.45%
| Year | ROE | Change |
|---|---|---|
| 2025 | 80.96% | -72.13% |
| 2024 | 290.52% | -87.94% |
| 2023 | 2.41% | -1413.52% |
| 2022 | -183.45% | 443.81% |
| 2021 | -33.73% | 35.64% |
| 2020 | -24.87% | -62.99% |
| 2019 | -67.19% | 51.75% |
| 2018 | -44.28% | 289.61% |
| 2017 | -11.36% | -73.84% |
| 2016 | -43.45% | 70.97% |
The current ROE of Ceryvyn Therapeutics Limited (CKDXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
927.03%
5-year avg
512.78%
10-year avg
237.28%
Ceryvyn Therapeutics Limited’s ROE is greater than Claritas Pharmaceuticals, Inc. (-436.27%), less than Inventiva S.A. (1.87%), less than Oxurion N.V. (29.96%), greater than Columbia Care Inc. (-106.90%), greater than TerrAscend Corp. (-82.13%), less than Kindstar Globalgene Technology, Inc. (-2.13%), greater than SS Innovations International, Inc. (-23.00%), less than Adcock Ingram Holdings Limited (15.27%), greater than AnGes, Inc. (-156.47%), less than Dong Fang Hui Le Inc. (67.02%),
| Company | ROE | Market cap |
|---|---|---|
| -436.27% | $3.66K | |
| 1.87% | $499.23M | |
| 29.96% | $433.72M | |
| -106.90% | $521.35M | |
| -82.13% | $601.91M | |
| -2.13% | $675.13M | |
| -23.00% | $770.51M | |
| 15.27% | $624.32M | |
| -156.47% | $142.50M | |
| 67.02% | $400.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ceryvyn Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ceryvyn Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ceryvyn Therapeutics Limited's ROE?
How is the ROE calculated for Ceryvyn Therapeutics Limited (CKDXF)?
What is the highest ROE for Ceryvyn Therapeutics Limited (CKDXF)?
What is the 3-year average ROE for Ceryvyn Therapeutics Limited (CKDXF)?
What is the 5-year average ROE for Ceryvyn Therapeutics Limited (CKDXF)?
How does the current ROE for Ceryvyn Therapeutics Limited (CKDXF) compare to its historical average?